Soleno Therapeutics, Inc.SLNONASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P74
Within normal range
vs 2Y Ago
40.4x
Strong expansion
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 11.49% |
| Q3 2025 | 445.81% |
| Q2 2025 | 61.48% |
| Q1 2025 | -36.49% |
| Q4 2024 | -58.76% |
| Q3 2024 | 14.39% |
| Q2 2024 | -40.83% |
| Q1 2024 | -98.59% |
| Q4 2023 | 0.28% |
| Q3 2023 | -13.76% |
| Q2 2023 | 17.27% |
| Q1 2023 | -30.67% |
| Q4 2022 | -10.42% |
| Q3 2022 | -0.78% |
| Q2 2022 | 27.27% |
| Q1 2022 | 7.48% |
| Q4 2021 | -27.07% |
| Q3 2021 | 32.47% |
| Q2 2021 | -6.95% |
| Q1 2021 | -9.04% |
| Q4 2020 | -11.42% |
| Q3 2020 | 5.62% |
| Q2 2020 | -15.46% |
| Q1 2020 | -11.38% |
| Q4 2019 | -7.67% |
| Q3 2019 | -21.03% |
| Q2 2019 | -5.46% |
| Q1 2019 | 1.10% |
| Q4 2018 | -39.37% |
| Q3 2018 | 2.51% |
| Q2 2018 | -9.17% |
| Q1 2018 | 52.43% |
| Q4 2017 | -133.14% |
| Q3 2017 | 17.89% |
| Q2 2017 | -26.52% |
| Q1 2017 | 18.63% |
| Q4 2016 | 3.60% |
| Q3 2016 | 31.33% |
| Q2 2016 | -1.42% |
| Q1 2016 | -14.83% |